Actively Recruiting

Phase Not Applicable
Age: 55Years +
All Genders
Healthy Volunteers
NCT06024473

A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI

Led by Central Arkansas Veterans Healthcare System · Updated on 2025-02-20

50

Participants Needed

1

Research Sites

126 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This clinical trial is being conducted to see if brain stimulation and brain training together improves cognitive functioning and mood in older adults diagnosed with Mild Cognitive Impairment (MCI). Brain stimulation will be done using repetitive Transcranial Magnetic Stimulation (rTMS). Brain training will be done using immersive virtual reality cognitive training (iVCT) program. The goals of this clinical trail are as follows: * Examine if rTMS+iVCT intervention can improve and sustain objective cognitive functioning in individuals with MCI more than control or rTMS only groups * Examine if rTMS+iVCT intervention improves participants mental health symptoms, functional abilities, and quality of life more than control or rTMS only groups * Examine the impact of rTMS+iVCT intervention on caregiver burden. Eligible participants will be assigned to a standard treatment (no intervention control) group, rTMS only group of rTMS+iVCT group. All participants will undergo baseline assessment to evaluate their cognitive, emotional, and functional abilities. Those in the rTMS only group will receive rTMS treatments for five days per week for two weeks (total of ten sessions). Those in the rTMS+iVCT group will receive rTMS treatment followed by iVCT training for five days a week for two weeks (total of ten sessions). All participants will then repeat testing 2 weeks and three months after baseline testing to assess for possible treatment related changes and lasting effects.

CONDITIONS

Official Title

A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI

Who Can Participate

Age: 55Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 55 and over
  • Previous diagnosis of Mild Cognitive Impairment
  • Score of 18 or over on the MoCA during pre-screening procedures
Not Eligible

You will not qualify if you...

  • Below 55 years old
  • Do not pass the TMS Adult Safety Screening
  • Taking medications known to increase risk of seizure
  • Taking ototoxic medications
  • Presence of implanted medical devices
  • History of bipolar disorder
  • History of Tourette's syndrome or motor tics
  • History of seizures or seizures in first-degree relatives
  • History of stroke, aneurysm, or cranial neurosurgery
  • Current alcohol-related disorder needing medical treatment
  • History of abnormal electroencephalogram (EEG)
  • History of motion sickness, nausea, vomiting, seizures, or migraine
  • Significant balance or gait impairments or history of falls
  • History of hyperacusis or photophobia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Central Arkansas VA Healthcare system

Little Rock, Arkansas, United States, 72114

Actively Recruiting

Loading map...

Research Team

I

Ian Moore, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here